Filter posts

Congressman Stiver Continues Call for Sensible Patent Reform

Congressman Stiver Continues Call for Sensible Patent Reform While there is consensus across Capitol Hill …

Licensing of Research Has Had Huge Impact on Economy & Jobs

A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, …

How Will Brexit Impact Patients and Biotech Innovation?

The clock is beginning to run out for British Parliament to finalize a Brexit plan. …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

Patents Are The Lifeblood of Biotechnology

Strong patents are the lifeblood of the biotechnology industry. They are critical in ensuring a …

BIO’S Spring IPCC Conference Registration is Now OPEN! With Special Offer for First Time In-House ...

Pack your bags patent practitioners – We’re heading back to the French Quarter. Registration for BIO’s …

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …

ICYMI: Patent Abuse Is Undermining American Health Care

The pharmaceutical company Allergan recently announced a decision to transfer the intellectual property rights of …